INDV vs PATH
Indivior PLC Ordinary Shares (INDV) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Indivior PLC Ordinary Shares (INDV) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported INDV revenue for 2024-12-31 was $1.19B. Net income was $2.0M. Revenue was up 8.7% from 2023-12-31 to 2024-12-31. INDV currently screens at market cap $4.48B and trailing P/E 19.5.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
INDV currently screens at market cap $4.48B and trailing P/E 19.5. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the INDV and PATH stock pages for the full models.
Not investment advice.